Hiroko Yamamoto, Yoshikazu Murawaki, Hironaka Kawasaki – 1 January 1995 – To elucidate hepatic collagen metabolism during liver regeneration after partial hepatectomy, we measured collagen content, collagen synthesis, and collagen‐degrading enzyme activity in the remnant livers of rats 3, 5, 7, and 14 days after a partial hepatectomy of 68%.
Jay H. Hoofnagle, Robert L. Carithers, Craig Shapiro, Nancy Ascher – 1 January 1995 – Fulminant hepatic failure (FHF) is defined by the appearance of severe liver injury with hepatic encephalopathy in a previously healthy person. There are an estimated 2,000 cases of FHF in the United States yearly, representing 0.1% of all deaths and, perhaps, 6% of liverrelated deaths. The causes of FHF are many, the chief ones in the United States being hepatitis A; B; non‐A, non‐B and drug induced liver disease.
Eliane Moreira, Luis Fontana, José Luis Periago, Fermín Sánchez De Medina, Ángel Gil – 1 January 1995 – The aim of this study was to evaluate the changes in fatty acid composition of lipids of plasma, erythrocytes, and liver microsomes in rats with liver cirrhosis induced by oral intake of thioacetamide and to determine to what extent the experimental model reproduces the fatty acid tissue alterations reported in human cirrhosis. Two groups of rats were studied.
Harold Rosen – 1 January 1995
1 January 1995
Shunji Kawamoto, Russell W. Strong, Stephen V. Lynch, Tat Hin Ong, S. Praga Pillay, Junichi Yamanaka, Glenda A. Balderson – 1 January 1995 – Because of the anatomical features associated with situs inversus, technical difficulties will be encountered during orthotopic liver transplantation. This report describes the case of a patient with situs inversus totalis and end‐stage liver disease from biliary atresia who was treated by segmental orthotopic liver transplantation.
Helena Gylling, Martti Färkkilä, Matti Vuoristo, Tatu A. Miettinen – 1 January 1995 – Cholesterol absorption, elimination, and synthesis, and low‐density lipoprotein (LDL) and high density lipoprotein (HDL) kinetics were studied in patients with mild to severe primary biliary cirrhosis (PBC) (n = 16) to show how this cholestatic disease modified cholesterol and lipoprotein metabolism as compared with healthy controls (n = 50).
Goshi Shiota, Jun‐Ichi Okano, Hironaka Kawasaki, Tomokazu Kawamoto, Toshikazu Nakamura – 1 January 1995 – Although recent studies have shown that hepatocyte growth factor (HGF) is a potent mitogen in vivo, the significance of serum HGF in liver diseases remains unclear. To clarify clinical significance of serum HGF in liver diseases, serum HGF was measured in 127 patients with liver diseases and in 200 healthy individuals, using a highly sensitive immunoradiometric assay (IRMA). This assay is specific for HGF and is sensitive enough to detect 0.1 ng/mL of HGF.
Jacob George, Michael Murray, Karen Byth, Geoffrey C. Farrell – 1 January 1995 – To determine whether cytochrome P450 proteins were differentially altered in severe chronic liver diseases, we examined 50 livers removed at liver transplantation from patients with end‐stage cirrhosis, including 18 with and 32 without cholestasis, and compared the results with 21 histologically normal livers. NADPH‐cytochrome c reductase activities were unaltered in microsomes from cirrhotic livers. Total cytochrome P450 content was significantly reduced.
Howard J. Grossman, Virginia L. Grossman, Prithi S. Bhathal – 1 January 1995 – The relationship between the perfusion pressure (P) and resistance (R) of the intrahepatic portal vascular bed was determined in isolated rat liver preparations perfused with fresh, heparinized rat blood (hematocrit 30%), with rat blood containing a vasodilator agent (sodium nitroprusside, 1 × 10–3 mol/L), or with 2.5% bovine serum albumin in Krebs‐Henseleit buffer (BSA‐KH).